# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-25-006007
Filing Date
2025-04-30
Accepted
2025-04-30 16:30:20
Documents
25
Period of Report
2025-06-17

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | tmb-20250617xdef14a.htm iXBRL | DEF 14A | 2112079
2 | GRAPHIC | tmb-20250617xdef14a001.jpg | GRAPHIC | 14201
3 | GRAPHIC | tmb-20250617xdef14a002.jpg | GRAPHIC | 4301
4 | GRAPHIC | tmb-20250617xdef14a003.jpg | GRAPHIC | 6349
5 | GRAPHIC | tmb-20250617xdef14a004.jpg | GRAPHIC | 58633
6 | GRAPHIC | tmb-20250617xdef14a007.jpg | GRAPHIC | 46711
7 | GRAPHIC | tmb-20250617xdef14a018.jpg | GRAPHIC | 69192
8 | GRAPHIC | tmb-20250617xdef14a019.jpg | GRAPHIC | 59541
9 | GRAPHIC | tmb-20250617xdef14a020.jpg | GRAPHIC | 58434
10 | GRAPHIC | tmb-20250617xdef14a024.jpg | GRAPHIC | 5660
| Complete submission text file | 0001558370-25-006007.txt |  | 4359543

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
11 | EX-101.SCH | tmb-20250617.xsd | EX-101.SCH | 4397
12 | EX-101.DEF | tmb-20250617_def.xml | EX-101.DEF | 3406
13 | EX-101.LAB | tmb-20250617_lab.xml | EX-101.LAB | 5814
14 | EX-101.PRE | tmb-20250617_pre.xml | EX-101.PRE | 5000
27 | EXTRACTED XBRL INSTANCE DOCUMENT | tmb-20250617xdef14a_htm.xml | XML | 530518

Mailing Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059
Business Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35969 | Film No.: 25895926
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)